GL1X · GenesisL1 explorer

MolNFT v1 · #70601 · protein

Crystal structure of JAK2 complexed with a potent 2,8-diaryl- quinoxaline inhibitor

3LPB · Tyrosine-protein kinase JAK2: “Crystal structure of JAK2 complexed with a potent 2,8-diaryl- quinoxaline inhibitor”. X-ray diffraction, 1 ligand (NVB), 6 pockets (best druggability 0.70). MolNFT v1 #70601 on GenesisL1: 3D structure…

PDB
3LPB
Type
protein
Length
566 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
NVB
Pockets
6 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 45% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28045% helix, 20% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28644% helix, 19% strandO60674

Ligands and binding sites

  • NVB · N-methyl-4-[3-(3,4,5-trimethoxyphenyl)quinoxalin-5-yl]benzenesulfonamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14300.700.8149NVB
25800.670.7746empty
32230.640.8327NVB
41250.570.8429empty
51220.360.7322empty

Interfaces

1 interface between chains.

  • A–B · 522 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 3LPB · Crystal structure of Jak2 complexed with a potent 2,8-diaryl-quinoxaline inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.